Lymphocytic Infiltrate of Jessner is a rare chronic skin disorder characterized by the presence of lymphocytes infiltrating the skin. It typically presents as red or purple patches on the face, neck, or upper body. While this condition can be persistent, it is generally considered benign and does not affect life expectancy. Treatment options include topical corticosteroids, immunosuppressive medications, or phototherapy, which can help manage symptoms and reduce inflammation. It is important to consult with a dermatologist for an accurate diagnosis and appropriate treatment plan tailored to individual needs.
Lymphocytic infiltrate of Jessner, also known as Jessner lymphocytic infiltrate or Jessner-Kanof syndrome, is a rare chronic skin disorder characterized by the presence of infiltrating lymphocytes in the skin. It primarily affects middle-aged adults and is more common in women than men.
The exact cause of lymphocytic infiltrate of Jessner is unknown, and there is limited research on the long-term prognosis of this condition. However, it is generally considered a benign disorder with a good prognosis. The disease is typically chronic and may persist for many years, but it does not usually progress to more serious complications.
The main symptom of lymphocytic infiltrate of Jessner is the presence of raised, red or purple, slightly scaly patches or plaques on the skin. These lesions commonly occur on the face, neck, and upper trunk. They are usually asymptomatic or may cause mild itching or burning sensation.
Diagnosis of lymphocytic infiltrate of Jessner is made through a skin biopsy, which reveals a dense infiltration of lymphocytes in the upper layers of the skin. Other skin conditions with similar features, such as lupus erythematosus or cutaneous lymphoma, must be ruled out.
Treatment for lymphocytic infiltrate of Jessner is not always necessary, as the condition is usually benign and asymptomatic. However, if the lesions cause discomfort or cosmetic concerns, various treatment options can be considered. Topical corticosteroids, topical calcineurin inhibitors, or intralesional corticosteroid injections may be used to reduce inflammation and improve the appearance of the skin.
Overall, the life expectancy of someone with lymphocytic infiltrate of Jessner is not affected by the condition itself. It does not pose a significant risk to general health or increase the likelihood of developing other serious medical conditions. However, it is important to consult with a dermatologist for proper diagnosis and management of the condition.